Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.32 |
| ▸ | APLNR | P35414 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5485411 | 0.67 | ALDH1A1 (0.36) | CYP2C19ALDH1A1TP53TSHRALOX15 | |
| SCHEMBL8954801 | 0.67 | ALDH1A1 (0.36) | CYP2C19ALDH1A1TP53TSHRALOX15 | |
| SCHEMBL712898 | 0.67 | ALDH1A1 (0.36) | CYP2C19ALDH1A1TP53TSHRALOX15 | |
| SCHEMBL8954803 | 0.67 | ALDH1A1 (0.36) | CYP2C19ALDH1A1TP53TSHRALOX15 | |
| SCHEMBL8954795 | 0.67 | ALDH1A1 (0.36) | CYP2C19ALDH1A1TP53TSHRALOX15 | |
| SCHEMBL23651854 | 0.65 | EDNRA (0.37) | ALDH1A1TP53TSHRALOX15 | |
| SCHEMBL25192440 | 0.62 | GRM2 (0.34) | CYP2C19ALDH1A1TP53TSHRMAPK1 | |
| SCHEMBL11041869 | 0.61 | FFAR3 (0.33) | ALDH1A1TP53TSHRSMN1; SMN2HSD17B10 | |
| Bicarbonate SCHEMBL139212 | 0.57 | — | — | |
| SCHEMBL676573 | 0.56 | POLB (0.47) | CYP2C19ALDH1A1TP53TSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6111059-A | LIQUID CRYSTAL DISPLAY DEVICE; HEAT RESISTANCE AND SOLVENT RESISTANCE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-08-29 | — | — | US | claimed |
| EP-0905167-A1 | DIAMINOBENZENE DERIVATIVES, POLYIMIDES PREPARED THEREFROM, AND ALIGNMENT FILM FOR LIQUID CRYSTALS | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1999-03-31 | — | — | EP | claimed |
| JP-5072538-A | — | — | None | — | — | JP | disclosed |
| WO-2024057206-A1 | POLYIMIDE ADHESIVE COMPOSITION COMPRISING MALEIMIDE MOIETIES AND AMINE COMPOUND, ARTICLES AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-03-21 | — | — | WO | disclosed |
| US-11384092-B2 | Dianhydride compound having rigid alicyclic fluorine-containing structure, and preparation method and use thereof | HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2022-07-12 | — | — | US | disclosed |
| US-20210094965-A1 | DIANHYDRIDE COMPOUND HAVING RIGID ALICYCLIC FLUORINE-CONTAINING STRUCTURE, AND PREPARATION METHOD AND USE THEREOF | HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2021-04-01 | — | — | US | disclosed |
| US-20150232665-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT HAVING THEREOF | CHI MEI CORPORATION (TW) | 2015-08-20 | — | — | US | disclosed |
| JP-H0572538-A | FORMATION OF LIQUID CRYSTAL ORIENTING FILM | SHARP CORP | 1993-03-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11384092-B2 | Dianhydride compound having rigid alicyclic fluorine-containing structure, and preparation method and use thereof | CA3, MLLT3, TET3 | CYP2C19 3299/4885ALDH1A1 357/4885TP53 3029/4885 |
| US-20210094965-A1 | DIANHYDRIDE COMPOUND HAVING RIGID ALICYCLIC FLUORINE-CONTAINING STRUCTURE, AND PREPARATION METHOD AND USE THEREOF | CA3, MLLT3, TET3 | CYP2C19 3299/4885ALDH1A1 357/4885TP53 3029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.